Newsfeeds - Spark Newswire

4 minute read

ARS Pharmaceuticals Closes Merger With Silverback Therapeutics; neffy NDA Currently Under FDA Review; PDUFA Anticipated Mid-2023 MAA Validated In The European Union Under Review

Today, 1:39 PM

Over $280 Million in Combined Cash and Securities and at least Three Years Operating Runway to Support Launch and Commercialization of neffy® in the U.S., if Approved neffy® NDA

SBTX

2 minute read

FDA
News

Silverback Therapeutics Announced FDA’s Acceptance of ARS Pharmaceuticals’ NDA for Neffy (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) Including Anaphylaxis

By Charles Gross

Today, 1:39 PM

Silverback Therapeutics, Inc. (Nasdaq: SBTX) ("Silverback") today announced that the U.S.

SBTX

5 minute read

This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday

By Lisa Levin

Today, 1:39 PM

Gainers

AAMC

3 minute read

This Consumer Defensive Stock Is Trading Higher By Around 49%, Here Are 46 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 1:39 PM

Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares gained 93% to $10.32. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.

AAMC